About Atovaquone,Proguanil Hydrochloride
            
            Class: | Antimalarial agent  
Use: | Treatment and prevention of malaria caused by Plasmodium falciparum, including multidrug-resistant strains  
Adult dose: | For treatment: 4 tablets (100 mg atovaquone/250 mg proguanil) once daily for 3 days; for prevention: 1 tablet once daily, starting 1-2 days before travel and continuing for 7 days after leaving the endemic area  
Pediatric dose: | For treatment: Children weighing 11-20 kg: 1 tablet once daily; 21-30 kg: 2 tablets once daily; 31-40 kg: 3 t
         
        
            
                
                
                    
                        Drug Class
                    
                    Antimalarial agent
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment and prevention of malaria caused by Plasmodium falciparum, including multidrug-resistant strains
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (15-30°C or 59-86°F) in a tightly closed container, protected from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Glaxo Wellcome SA, SPAIN
                    
                    
                    Package Size
                    12s
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 148.02
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        For treatment: 4 tablets (100 mg atovaquone/250 mg proguanil) once daily for 3 days; for prevention: 1 tablet once daily, starting 1-2 days before travel and continuing for 7 days after leaving the endemic area
                    
                    
                        Pediatric Dose
                    
                    
                        For treatment: Children weighing 11-20 kg: 1 tablet once daily; 21-30 kg: 2 tablets once daily; 31-40 kg: 3 tablets once daily for 3 days; for prevention: Children weighing 11-20 kg: 1 tablet once daily; 21-30 kg: 2 tablets once daily; 31-40 kg: 3 tablets once daily
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, abdominal pain, headache, diarrhea, dizziness, insomnia
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to atovaquone, proguanil, or any component of the formulation; severe renal impairment (creatinine clearance <30 mL/min)
         
        
        
            
                Important Warnings
            
            Use with caution in patients with renal impairment; may cause gastrointestinal disturbances; not recommended for use during pregnancy unless clearly needed; potential for drug interactions with other medications affecting liver enzymes
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.